Speaker illustration

Doctor Par Paren

Sahlgrenska University Hospital/Mölndal, Department of Internal Medicine, Mölndal (Sweden)

Member of:

Heart Failure Association

Trends in diuretic treatment between 2005 and 2011 in patients with heart failure

Event: ESC CONGRESS 2017

Topic: Pharmacologic therapy

Session: Chronic heart failure (CHF)

Thumbnail

Risk of long-term mortality associated with diuretic treatment in 17,519 heart failure outpatients was increased with 42% after adjustment for MAGGIC mortality risk predictors

Event: ESC CONGRESS 2016

Topic: Pharmacologic therapy

Session: Drug therapy in heart failure

Thumbnail

Adherence to international guidelines on diuretic treatment in heart failure based on congestive signs in 43,744 patients from SwedeHF

Event: ESC CONGRESS 2016

Topic: Pharmacologic therapy

Session: Pharmacologic approaches in HF: could we do better?

Thumbnail

This platform is supported by

logo Novo Nordisk